Anabolic Agents and the Body: The Pharmacology of Performance, Without Myths - Episode 2: How the Androgen Receptor Works

1. The androgen receptor: the central component of androgen signaling

Testosterone is not itself the final instruction received by the cell. It is a hormonal signal that must be detected and interpreted. The androgen receptor, or AR, is the protein that converts the presence of an androgen into a cellular response. Without the receptor, a higher hormone concentration does not automatically become activation of target genes.

AR belongs to the nuclear receptor family. This family acts as a system for regulating gene expression: the ligand changes the receptor's state, and the receptor influences which genes become more or less active. For androgens, this process is essential for androgen-dependent development and maintenance and contributes to the homeostasis of tissues such as muscle and bone.

2. Where is the androgen receptor located?

AR can move between cellular compartments. In the absence of ligand, the receptor is associated with chaperone proteins, including HSP90, which help maintain a conformation compatible with the resting state and with later ligand-induced changes. After androgen binding, the receptor changes its structural organization and can participate in transport toward the nucleus.

3. Step one: the androgen enters the cell

Testosterone and other androgens are lipophilic molecules, allowing them to cross the cell membrane. Inside the cell, the ligand can encounter the androgen receptor. Testosterone can also be converted to dihydrotestosterone, DHT, by 5-alpha-reductase or to estradiol by aromatase, and these transformations change the hormonal signal that reaches the corresponding receptors.

4. Ligand binding changes the shape of the receptor

AR is not simply a pocket that receives testosterone and remains unchanged. Ligand binding produces conformational changes in the ligand-binding domain. In other words, the receptor changes shape and, through that change, modifies its interaction surfaces with other proteins.

This structural plasticity is one of the central ideas in androgen pharmacology. Different ligands can favor different receptor conformations, and conformation influences which molecular partners are recruited and how efficiently the signal is transmitted. That is why two molecules binding the same receptor do not necessarily produce exactly the same biological response.

5. Why do HSP90 and chaperone proteins matter?

In the unbound state, AR forms complexes with chaperone proteins that stabilize its conformation. HSP90 should not be viewed as merely a passive protector. It participates in maintaining the receptor in a state that permits ligand binding and later reorganization of the receptor-protein complex. Receptor activation involves changes in these interactions.

6. Step two: the receptor moves toward the nucleus

After ligand-dependent activation, AR can use nuclear localization signals and intracellular transport systems to reach the nucleus. This is where DNA is located, and DNA contains regulatory regions of genes that the receptor can influence.

Nuclear translocation is not the end of the process. The receptor must be able to interact with chromatin, recognize androgen response elements, and recruit proteins that alter gene accessibility and transcription.

7. The structure of AR explains its function

AR contains several major functional domains. The N-terminal domain contributes strongly to transcriptional activation. The DNA-binding domain recognizes specific DNA sequences. The hinge region contributes to nuclear localization and other interactions. The C-terminal ligand-binding domain receives the androgen and participates in establishing the active conformation.

These domains do not work as completely independent modules. They communicate through intramolecular interactions. This architecture allows the receptor to turn a small event, the binding of one molecule, into a cascade of functional changes.

8. Step three: DNA binding

In the nucleus, activated AR recognizes regulatory sequences called androgen response elements, or AREs. The receptor's DNA-binding domain is responsible for this recognition. In many contexts, the receptor associates in a dimeric form to occupy the DNA region and organize transcriptional machinery.

Here an important nuance appears: DNA is not a simple list of on-off switches. The position of the ARE, chromatin organization, tissue-specific transcription factors, and the availability of coactivators or corepressors all contribute to the intensity and nature of the response.

9. Coactivators: the receptor does not work alone

An androgen receptor bound to DNA does not automatically produce maximal transcription. It must recruit coactivators and other components of the transcriptional apparatus. These proteins can remodel chromatin, modify histones, and facilitate interaction with complexes that produce messenger RNA.

This helps explain why androgen responses are tissue-dependent. Two cells that express AR can respond differently to the same ligand if they have different sets of cofactors, chromatin states, and transcriptional programs.

10. What does transactivation mean?

Transactivation is the process by which activated AR contributes to increased transcription of particular genes. In practical terms, the hormonal signal is converted into a change in the gene-expression program. For some genes the response can be activation, while in other contexts androgen signaling can indirectly contribute to repression of certain programs.

11. From DNA to RNA and then to protein

After transcriptional complexes are recruited, information in DNA is copied into messenger RNA. The RNA is then processed and exported to the cytoplasm, where ribosomes translate it into proteins. In this way, an androgen signal can change the abundance of proteins and cellular function over longer time scales.

12. How does this mechanism relate to muscle?

In skeletal muscle, androgens influence processes involved in tissue maintenance and remodeling. The effects cannot be reduced to one gene or one protein. AR signaling interacts with protein synthesis, cellular differentiation, regeneration, and metabolism, and the outcome depends on training, nutrition, and hormonal status.

That is why the simple formula 'more testosterone equals more strength' misses the mechanism. Ligand concentration, receptor sensitivity and expression, cofactor availability, cellular state, and training adaptations are all part of the same system.

13. The androgen receptor is not the same thing as protein synthesis

AR is a transcriptional regulator, not a ribosome and not a protein-synthesis enzyme. Its activation can contribute to a cellular environment that favors anabolic adaptations, but muscle protein production involves many other pathways, including IGF-1, PI3K-AKT-mTOR, and mechanosensitive signaling. Androgens and these pathways can influence one another, but they are not the same pathway.

14. Androgens can also influence non-genomic pathways

The best-known function of AR is transcriptional regulation, but the literature also describes more rapid responses associated with cytoplasmic signaling and interactions with other signaling proteins. These non-genomic mechanisms do not replace genomic action, but they can contribute to the complexity of the cellular response.

15. Why are two androgens not identical?

Androgenic molecules differ in structure, AR affinity, metabolism, duration of exposure, and tissue distribution. A small structural change can alter the pharmacological properties of a molecule and therefore the receptor and tissue exposure profile.

Testosterone, DHT, and synthetic steroids can produce different responses even when they signal through the same receptor. Some derivatives are metabolized differently, some resist particular enzymes longer, and others have properties that change systemic and local availability.

16. Testosterone and DHT: the same receptor, nuanced signals

Testosterone and DHT bind the same androgen receptor, but DHT has higher affinity and can produce a somewhat different activation profile. In addition, testosterone can be aromatized to estradiol, whereas DHT is not a substrate for aromatase. Thus the biological effect of testosterone is not reducible to AR, because its metabolism also produces signals that act through other receptors.

17. What happens when androgen concentration becomes very high?

When androgen exposure is far above physiological levels, the androgen receptor system is operating in a pharmacological context rather than an ordinary physiological one. Receptor stimulation increases, but so do consequences for other endocrine and metabolic systems. More signal does not simply mean more muscle effect; it also means greater disturbance of homeostasis.

With AAS, exogenous androgens can suppress the hypothalamic-pituitary-gonadal axis through negative feedback. The body can therefore reach a state in which external androgen signaling is high while endogenous testosterone production is reduced.

18. The androgen receptor and 'saturation'

It is tempting to describe AR as a receptor that simply fills up and stops. Biology is more complicated. The response depends on ligand concentration, receptor occupancy, ligand-induced conformation, exposure duration, cofactor levels, and chromatin state. Cells can also alter receptor expression and other components of the signaling system.

19. AR can be modified after ligand binding

The androgen receptor is a dynamic protein and can undergo post-translational modifications, including phosphorylation, acetylation, ubiquitination, and methylation. These modifications can influence localization, stability, cofactor interactions, and transcriptional activity.

20. The receptor and chromatin

Inside the nucleus, AR interacts with a genome packaged into chromatin. Access to DNA is not uniform. Chromatin-remodeling complexes can alter accessibility, and the receptor can recruit or cooperate with such complexes. Thus AR activation is also a problem of chromatin architecture, not just recognition of a DNA sequence.

21. Why does the tissue containing the receptor matter?

The same molecule can produce different effects in muscle, prostate, bone, or skin. The receptor is part of a local network of enzymes, transcription factors, and cofactors. In addition, the local concentration of androgen metabolites can differ from their concentration in blood.

22. Why aren't 'anabolic' and 'androgenic' two separate switches?

The terms anabolic and androgenic describe categories of effects, not two independent receptors. AAS are testosterone-derived compounds that act through the androgenic system, and perfect separation of muscle-building effects from androgenic effects is not achieved in a simple way in humans.

Some molecules have been designed to alter this relationship, but real tissue selectivity is complex and a class label does not automatically make an androgen risk-free.

23. What are androgen receptor antagonists?

AR antagonists can occupy the receptor or interfere with its function without producing the same transcriptional activation as an androgen agonist. Some molecules stabilize conformations that favor corepressor recruitment or interfere with steps required for activation. This is one reason AR is an important pharmacological target in several diseases.

24. What happens after the signal disappears?

AR signaling is dynamic. The ligand can dissociate from the receptor, the receptor can redistribute between compartments, and transcriptional complexes can assemble and disassemble. AR can undergo repeated cycles of nuclear localization and recycling, helping explain the dynamic nature of androgen signaling.

25. What does the mechanism mean for a strength athlete?

For a strength athlete, AR signaling matters because androgens can alter the biological environment in which muscle adapts to training. However, the receptor cannot replace training mechanics. Without an adequate mechanical stimulus, sufficient energy and protein intake, and recovery, increasing androgen signaling does not automatically turn the body into a hypertrophy machine.

At the same time, high pharmacological exposure can increase mass and recovery capacity, but it does not make tissues invulnerable. Muscle can adapt faster than tendons, ligaments, or other components of the musculoskeletal system, and strength gains can carry a biomechanical cost.

26. Why does the androgen receptor not explain every AAS effect?

AAS can influence several systems at the same time. Beyond AR, there are metabolic, cardiovascular, hepatic, reproductive, and endocrine effects. Some consequences arise from metabolite activity, while others are related to changes in lipids, erythropoiesis, blood pressure, or hormonal axes.

27. What does pharmacology say about a 'better receptor'?

There is no 'better' androgen receptor in the simplistic sense. There are differences in affinity, ligand-induced conformation, available cofactors, receptor expression, and tissue context. A molecule that produces a strong signal in an experimental system is not automatically more effective or safer in humans.

28. Myth: 'higher affinity automatically means more muscle'

Receptor affinity is only one piece of the puzzle. Free ligand concentration, exposure duration, tissue distribution, metabolism, half-life, receptor abundance, and cofactor networks also matter. Real pharmacology therefore cannot be reduced to a single affinity number.

29. Myth: 'if the receptor is stimulated, every effect is anabolic'

AR activation is associated with anabolic and androgenic effects, but also with tissue-dependent and context-dependent effects. In humans, the response is a product of the whole endocrine and metabolic network. An increase in muscle mass can therefore coexist with unfavorable changes in blood pressure, lipids, fertility, or liver function depending on compound and exposure.

30. Myth: 'the receptor gets used to it and disappears'

Cells can modify receptor levels and signaling pathways after repeated exposure, but the statement 'the receptor disappears' is too simplistic. Downregulation, cofactor changes, chromatin alterations, and endocrine feedback can change the response. The phenomenon can also differ between tissues.

31. The mechanism in eight steps

A useful way to view the system is: 1) an androgen reaches the cell; 2) it binds AR; 3) the receptor changes conformation; 4) the complex is reorganized and moves toward the nucleus; 5) AR interacts with DNA and chromatin; 6) coactivators and other transcriptional components are recruited; 7) expression of selected genes changes; 8) the altered cellular program contributes, together with other pathways, to the physiological or pharmacological effect.

32. Conclusion

The androgen receptor is better understood as a molecular command center than as a simple 'muscle switch'. It reads a hormonal signal, changes conformation, reorganizes its partners, reaches DNA, and influences transcription. The final result depends on the ligand, tissue, chromatin, cofactors, metabolism, and physiological context.

Understanding AR is essential for understanding why anabolic-androgenic steroids can produce major increases in mass and performance while also profoundly disturbing whole-body homeostasis. Pharmacology begins with the receptor, but it does not end there.

Selected bibliography

1. Brinkmann AO et al. Mechanisms of androgen receptor activation and function. PubMed PMID: 10419007.

2. Georget V et al. Mechanism of antiandrogen action: key role of HSP90 in conformational change and transcriptional activity of the androgen receptor. PubMed PMID: 12269826.

3. Wang C et al. Androgen receptor: structural domains and functional dynamics after ligand-receptor interaction. PubMed PMID: 11795379.

4. Chmelar R et al. The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptor. PubMed PMID: 15563469.

5. van Royen ME et al. Ligand-specific dynamics of the androgen receptor at its response element in living cells. PubMed PMID: 17189428.

6. Structural perspectives on the androgen receptor, the elusive shape-shifter. PubMed PMID: 39208923.

7. Androgens as the 'old age stick' in skeletal muscle. Review of androgen/AR signaling and muscle homeostasis, 2025.